Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 18th Jul 2014 07:55

Barclays: Credit Suisse cuts target price from 275p to 235p retaining a neutral rating.Barratt Developments: Liberum Capital reduces target price from 468p to 387p and downgrades to hold.Bellway: Liberum Capital reduces target price from 1900p to 1764p, while leaving its buy recommendation unchanged.Berkeley Group: Liberum Capital cuts target price from 2634p to 2613p retaining a hold recommendation.Bovis Homes Group: Liberum Capital reduces target price from 1034p to 930p and stays with its buy recommendation.Breedon: Jefferies shifts target price from 45p to 47p and reiterates a hold recommendation.British Land: Barclays raises target price from 695p to 936p, while its overweight rating remains unchanged.Burberry Group: Exane upgrades to outperform with a target price of 1700p.bwin.party: Deutsche Bank lowers target price from 110p to 100p and reiterates a hold recommendation.Croda International: Berenberg reduces target price from 2850p to 2700p, while keeping its buy recommendation.Drax Group: UBS moves target price from 790p to 800p and stays with its buy recommendation.GKN: Citi lowers target price from 435p to 410p, while staying with its buy recommendation.Gleeson: Liberum Capital cuts target price from 481p to 466p keeping a buy recommendation.Hays: Credit Suisse lowers target price from 165p to 150p and reiterates an outperform rating.Hikma Pharmaceuticals: Goldman Sachs raises target price from 1800p to 2250p and upgrades to buy.Hochschild Mining: Citi shifts target price from 110p to 116p, but still recommends selling.Howden Joinery: Berenberg initiates with a target price of 390p and a buy recommendation.Lloyds Banking Group: Citi lowers target price from 83p to 80p and retains a neutral rating.ISG: Jefferies shifts target price from 389p to 390p and keeps a buy recommendation.Michael Page: Credit Suisse cuts target price from 530p to 510p and maintains an outperform rating.Persimmon: Liberum Capital reduces target price from 1303p to 1238p and reiterates a hold recommendation.Reckitt Benckiser: Numis initiates with a target price of 5600p and an add rating.Redrow: Liberum Capital cuts target price from 320p to 307p and stays with its buy recommendation.Ricardo: Oriel raises target price to 700p and upgrades from reduce to buy.Robert Walters: Credit Suisse cuts target price from 380p to 360p and stays with its outperform rating.Standard Chartered: Deutsche Bank reduces target price from 1275p to 1160p and maintains a hold recommendation.SThree: Credit Suisse cuts target price from 450p to 420p and downgrades to neutral.Taylor Wimpey: Liberum Capital lowers target price from 132p to 130p maintaining a buy recommendation.Thorntons: Oriel initiates with a target price of 160p and a buy recommendation.William Hill: UBS cuts target price from 420p to 390p and retains a buy recommendation.
More News
2 Dec 2020 13:11

Wednesday broker round-up

(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.

Read more
24 Nov 2020 13:33

Tuesday broker round-up

(Sharecast News) - Glencore: Jefferies upgrades to buy with a target price of 250p.

Read more
10 Nov 2020 13:17

Tuesday broker round-up

(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.

Read more
10 Nov 2020 09:44

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

Read more
5 Nov 2020 10:44

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

TOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US

Read more
5 Nov 2020 09:24

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

LONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support

Read more
5 Nov 2020 09:15

Hikma raises FY guidance for generics unit following positive H1 momentum

(Sharecast News) - Pharmaceutical company Hikma said on Thursday that the group as a whole was "performing well" and had maintained the positive momentum seen in the first half, leading it to reiterate guidance for one unit and raise it on another.

Read more
4 Nov 2020 17:06

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

Read more
4 Nov 2020 12:12

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

Read more
4 Nov 2020 10:38

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

Read more
29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Oct 2020 11:03

Hikma Pharmaceuticals Expands US Collaboration With Arecor

Hikma Pharmaceuticals Expands US Collaboration With Arecor

Read more
1 Oct 2020 09:42

UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC

UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
22 Sep 2020 17:04

LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain

LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.